{
  "quoteSummary": {
    "result": [
      {
        "defaultKeyStatistics": {
          "maxAge": 1,
          "priceHint": {
            "raw": 2,
            "fmt": "2",
            "longFmt": "2"
          },
          "enterpriseValue": {
            "raw": 823807936,
            "fmt": "823.81M",
            "longFmt": "823,807,936"
          },
          "forwardPE": {},
          "profitMargins": {
            "raw": -0.13692,
            "fmt": "-13.69%"
          },
          "floatShares": {
            "raw": 37080553,
            "fmt": "37.08M",
            "longFmt": "37,080,553"
          },
          "sharesOutstanding": {
            "raw": 76714600,
            "fmt": "76.71M",
            "longFmt": "76,714,600"
          },
          "sharesShort": {},
          "sharesShortPriorMonth": {},
          "sharesShortPreviousMonthDate": {},
          "dateShortInterest": {},
          "sharesPercentSharesOut": {},
          "heldPercentInsiders": {},
          "heldPercentInstitutions": {},
          "shortRatio": {},
          "shortPercentOfFloat": {},
          "beta": {
            "raw": 0.395223,
            "fmt": "0.4"
          },
          "morningStarOverallRating": {},
          "morningStarRiskRating": {},
          "category": null,
          "bookValue": {
            "raw": 2.548,
            "fmt": "2.55"
          },
          "priceToBook": {
            "raw": 5.431711,
            "fmt": "5.43"
          },
          "annualReportExpenseRatio": {},
          "ytdReturn": {},
          "beta3Year": {},
          "totalAssets": {},
          "yield": {},
          "fundFamily": null,
          "fundInceptionDate": {},
          "legalType": null,
          "threeYearAverageReturn": {},
          "fiveYearAverageReturn": {},
          "priceToSalesTrailing12Months": {},
          "lastFiscalYearEnd": {
            "raw": 1490918400,
            "fmt": "2017-03-31"
          },
          "nextFiscalYearEnd": {
            "raw": 1553990400,
            "fmt": "2019-03-31"
          },
          "mostRecentQuarter": {},
          "earningsQuarterlyGrowth": {},
          "revenueQuarterlyGrowth": {},
          "netIncomeToCommon": {
            "raw": -192059008,
            "fmt": "-192.06M",
            "longFmt": "-192,059,008"
          },
          "trailingEps": {
            "raw": -2.506,
            "fmt": "-2.51"
          },
          "forwardEps": {},
          "pegRatio": {},
          "lastSplitFactor": null,
          "lastSplitDate": {},
          "enterpriseToRevenue": {
            "raw": 0.587,
            "fmt": "0.59"
          },
          "enterpriseToEbitda": {
            "raw": 186.045,
            "fmt": "186.04"
          },
          "52WeekChange": {
            "raw": 0.8094646,
            "fmt": "80.95%"
          },
          "SandP52WeekChange": {
            "raw": 0.17201865,
            "fmt": "17.20%"
          },
          "lastDividendValue": {},
          "lastCapGain": {},
          "annualHoldingsTurnover": {}
        },
        "summaryProfile": {
          "address1": "Shanti Sadan",
          "address2": "Mirzapur Road",
          "city": "Ahmedabad",
          "zip": "380001",
          "country": "India",
          "phone": "91 79 2550 7671",
          "fax": "91 79 2550 7483",
          "industry": "Drug Manufacturers - Major",
          "sector": "Healthcare",
          "longBusinessSummary": "Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, trades in, and deals in pharmaceuticals internationally. It operates through Pharmaceuticals and Electronics & Broadcast Equipments segments. The company offers drug and pharmaceutical formulations; products for oncology, infertility, and Uro-gynaec areas under the Sarabhai house brand name; generic products; antifungal active; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video and audio products, and electronic instruments and services. Ambalal Sarabhai Enterprises Limited markets its pharmaceutical products through its distributors. The company also exports its pharmaceutical products. Ambalal Sarabhai Enterprises Limited was incorporated in 1978 and is based in Ahmedabad, India.",
          "companyOfficers": [],
          "maxAge": 86400
        },
        "financialData": {
          "maxAge": 86400,
          "currentPrice": {
            "raw": 13.84,
            "fmt": "13.84"
          },
          "targetHighPrice": {},
          "targetLowPrice": {},
          "targetMeanPrice": {},
          "targetMedianPrice": {},
          "recommendationMean": {},
          "recommendationKey": "none",
          "numberOfAnalystOpinions": {},
          "totalCash": {},
          "totalCashPerShare": {},
          "ebitda": {
            "raw": 4428000,
            "fmt": "4.43M",
            "longFmt": "4,428,000"
          },
          "totalDebt": {},
          "quickRatio": {
            "raw": 0.4,
            "fmt": "0.40"
          },
          "currentRatio": {
            "raw": 0.58,
            "fmt": "0.58"
          },
          "totalRevenue": {
            "raw": 1402695040,
            "fmt": "1.4B",
            "longFmt": "1,402,695,040"
          },
          "debtToEquity": {},
          "revenuePerShare": {
            "raw": 18.304,
            "fmt": "18.30"
          },
          "returnOnAssets": {
            "raw": -0.01451,
            "fmt": "-1.45%"
          },
          "returnOnEquity": {
            "raw": -0.65933,
            "fmt": "-65.93%"
          },
          "grossProfits": {
            "raw": 589659000,
            "fmt": "589.66M",
            "longFmt": "589,659,000"
          },
          "freeCashflow": {
            "raw": 68663248,
            "fmt": "68.66M",
            "longFmt": "68,663,248"
          },
          "operatingCashflow": {
            "raw": 51312000,
            "fmt": "51.31M",
            "longFmt": "51,312,000"
          },
          "earningsGrowth": {},
          "revenueGrowth": {},
          "grossMargins": {
            "raw": 0.42038,
            "fmt": "42.04%"
          },
          "ebitdaMargins": {
            "raw": 0.00316,
            "fmt": "0.32%"
          },
          "operatingMargins": {
            "raw": -0.02795,
            "fmt": "-2.80%"
          },
          "profitMargins": {
            "raw": -0.13692,
            "fmt": "-13.69%"
          },
          "financialCurrency": "INR"
        }
      }
    ],
    "error": null
  }
}